Consensus statement on the use of biosimilar drugs in immune-mediated diseases in Spain Emilio Monte-Boquet; Ángeles Florez; Guillermo José Alcaín Martínez; Agustí Sellas;

Practical aspects of biological throught levels and antidrug antibodies in rheumatoid arthritis and spondyloarthritis José Rosas; María Martín-López; Teresa Otón; Alejandro Balsa; Jaime Calvo-Alén; Raimon Sanmartí; Jesús Tornero; Loreto Carmona;

Not the same, but is it the same? Cycling of biologic agents in rheumatoid arthritis. Experience in the Instituto Mexicano del Seguro Social Francisco Javier Aceves-Ávila; José Ramiro Hernández Vásquez; Sandra Sicsick; María de Lourdes Olguín Ortega; María Azucena Ramos Sánchez; Adelfia Urenda Quezada; Lizbet Tinajero Nieto; Freddy Jose Faccin; Miguel Angel Ramírez Ramírez; Natali Serra-Bonett; Angel Mario Coll Muñoz;